Efficacy and Safety of the Liquid Embolic System (Tonbridge) for Endovascular Treatment of Cerebrovascular Malformations

A trial with no phase registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 170 participants.

Also called NCT06479343

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 170 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT06479343
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
China (from the registry)
Registry status
  • Unknown status (from the registry)

Technical summary

Registry record NCT06479343. Randomized; no masking; primary purpose treatment. Start 2024-06-27 (actual); primary completion 2025-10 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Efficacy and Safety of the Liquid Embolic System (Tonbridge) for Endovascular Treatment of Cerebrovascular Malformations
Condition
Intracranial Arteriovenous Malformations
Intervention (Device)
Liquid Embolic System (Tonbridge)
Intervention (Device)
Onyx Liquid Embolic System (Medtronic)
Lead sponsor
Ton-Bridge Medical Tech. Co., Ltd (class: industry)

Record details

Record id
cardio:ct-nct06479343
Content hash
8642445a8b5d3a8da34d84b0545f5c08ffae152c7bdb9a8bbd1d8dd88520ebc8